LAZARD ASSET MANAGEMENT LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 163 filers reported holding ADMA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$370
+17.8%
103,751
+21.4%
0.00%
Q2 2023$314
+21.7%
85,456
+9.5%
0.00%
Q1 2023$258
-14.6%
78,0270.0%0.00%
Q4 2022$302
-99.8%
78,0270.0%0.00%
Q3 2022$189,000
+22.7%
78,0270.0%0.00%
Q2 2022$154,000
+81.2%
78,027
+66.5%
0.00%
Q1 2022$85,000
+54.5%
46,876
+18.5%
0.00%
Q4 2021$55,00039,5670.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders